Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis

COVID-19 vaccines are safe for people living with MS on or off disease-modifying therapies and are important for the prevention of COVID-19. Antibody responses for individuals on certain DMTs may be diminished, however, T-cell responses may be preserved in those individuals. Data are lacking regardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Robert K., Rammohan, Kottil W., Williams, Mitzi J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336531/
https://www.ncbi.nlm.nih.gov/pubmed/34347280
http://dx.doi.org/10.1007/s40120-021-00266-z
_version_ 1783733339346173952
author Shin, Robert K.
Rammohan, Kottil W.
Williams, Mitzi J.
author_facet Shin, Robert K.
Rammohan, Kottil W.
Williams, Mitzi J.
author_sort Shin, Robert K.
collection PubMed
description COVID-19 vaccines are safe for people living with MS on or off disease-modifying therapies and are important for the prevention of COVID-19. Antibody responses for individuals on certain DMTs may be diminished, however, T-cell responses may be preserved in those individuals. Data are lacking regarding optimal timing of vaccinations, and delaying disease-modifying therapies may increase the risk of disease activity and progression. In this perspective podcast, the authors recommend COVID-19 vaccination as soon as possible, regardless of timing considerations, in most cases. [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40120-021-00266-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-8336531
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-83365312021-08-06 Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis Shin, Robert K. Rammohan, Kottil W. Williams, Mitzi J. Neurol Ther Commentary COVID-19 vaccines are safe for people living with MS on or off disease-modifying therapies and are important for the prevention of COVID-19. Antibody responses for individuals on certain DMTs may be diminished, however, T-cell responses may be preserved in those individuals. Data are lacking regarding optimal timing of vaccinations, and delaying disease-modifying therapies may increase the risk of disease activity and progression. In this perspective podcast, the authors recommend COVID-19 vaccination as soon as possible, regardless of timing considerations, in most cases. [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40120-021-00266-z) contains supplementary material, which is available to authorized users. Springer Healthcare 2021-08-04 /pmc/articles/PMC8336531/ /pubmed/34347280 http://dx.doi.org/10.1007/s40120-021-00266-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Commentary
Shin, Robert K.
Rammohan, Kottil W.
Williams, Mitzi J.
Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis
title Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis
title_full Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis
title_fullStr Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis
title_full_unstemmed Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis
title_short Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis
title_sort expert perspectives on covid-19 vaccination for people living with multiple sclerosis
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336531/
https://www.ncbi.nlm.nih.gov/pubmed/34347280
http://dx.doi.org/10.1007/s40120-021-00266-z
work_keys_str_mv AT shinrobertk expertperspectivesoncovid19vaccinationforpeoplelivingwithmultiplesclerosis
AT rammohankottilw expertperspectivesoncovid19vaccinationforpeoplelivingwithmultiplesclerosis
AT williamsmitzij expertperspectivesoncovid19vaccinationforpeoplelivingwithmultiplesclerosis

Ejemplares similares